Jiangsu Hengrui Medicine Co., Ltd.
↗Lianyungang, China
Jiangsu Hengrui Medicine is a leading, fully integrated biopharmaceutical company based in China, recognized as one of the largest pharmaceutical companies in the country by market capitalization. The company specializes in the research, development, manufacturing, and commercialization of innovative medicines, with a primary focus on oncology, as well as cardiovascular, metabolic, immunological, and surgical therapeutic areas.
Since its founding in 1970, Hengrui has transformed from a generic drug manufacturer into a global innovator. It maintains a robust R&D pipeline with over 90 innovative drug candidates in clinical trials and operates 14 R&D centers worldwide. The company is publicly listed on the Shanghai Stock Exchange and completed a secondary listing on the Hong Kong Stock Exchange in May 2025.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$4.4B
Founded:1970
Ownership:public
Status:operating
FUNDING
Investors:Jiangsu Hengrui Medicine Group Co., Ltd., Tibet Dagze Huixin Investment Management Partnership
STOCK
Exchange:Shanghai Stock Exchange (SSE), Hong Kong Stock Exchange (HKEX)
Ticker:600276 (SSE)
Market Cap:$55.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, ADC
Active Trials:400
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:GSK (COPD therapy licensing, 2025), Merck & Co. (HRS-5346 licensing, 2025), IDEAYA Biosciences (SHR-4849 licensing, 2024), Incyte (PD-1 immunotherapy licensing, 2015)
COMPETITION
Position:Leader
Competitors:Akums, Rubicon, Jubilant Life Sciences
LEADERSHIP
Key Executives:
Lianshan Zhang - President of Global R&D
LINKS
Website:hengrui.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Jiangsu Hengrui Medicine Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Jiangsu Hengrui Medicine Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.